Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Delayed Quote. Delayed  - 09/23 05:31:07 pm
245.5 CHF   +0.16%
09/23 GLOBAL BLOOD GL : Roche, Lifescan, Bayer, Abbott, ARKRAY, I-SENS, Om..
09/23 MEDICINES : HHS forges strategic partnerships with two global compan..
09/23 MEDICINES : and Roche get BARDA awards to develop new antibiotics
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/19/2016 09/20/2016 09/21/2016 09/22/2016 09/23/2016 Date
242.5(c) 244.6(c) 243.6(c) 245.1(c) 245.5(c) Last
1 282 170 1 349 926 1 429 130 1 304 100 1 052 583 Volume
+1.00% +0.87% -0.41% +0.62% +0.16% Change
More quotes
Financials ( CHF)
Sales 2016 51 213 M
EBIT 2016 18 114 M
Net income 2016 11 293 M
Debt 2016 10 952 M
Yield 2016 3,48%
Sales 2017 53 836 M
EBIT 2017 19 311 M
Net income 2017 12 715 M
Debt 2017 5 248 M
Yield 2017 3,69%
P/E ratio 2016 18,41
P/E ratio 2017 16,50
EV / Sales2016 4,36x
EV / Sales2017 4,04x
Capitalization 212 096 M
More Financials
Company
Roche Holding AG operates as a research healthcare company.It operates through the diagnostics and pharmaceuticals segments.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The diagnostic segment... 
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
09/23 GLOBAL BLOOD GLUCOSE TEST STRIPS MAR : Roche, Lifescan, Bayer, Abbott, ARKRAY, I..
09/23 MEDICINES : HHS forges strategic partnerships with two global companies to devel..
09/23 MEDICINES : and Roche get BARDA awards to develop new antibiotics
09/23 ROCHE : Presolicitation Notice - Maintenance for the Roche Cedex Analyzer
09/22 ROCHE : $5.5 million to help nutley with roche transition
09/22 Epizyme Establishes Collaboration with Foundation Medicine to Support Tazemet..
09/22 ROCHE : Invitation to Roche's Third Quarter Sales 2016 Conference Call
09/20 ROCHE : ISPE Names 2016 Facility of the Year Awards Overall Winner
09/20 ROCHE : Combine Solicitation - 66-- Albuquerque NM VA CoaguChek Supplies Base pl..
09/16 Chugai Selected for the Third Consecutive Year for Dow Jones Sustainability A..
More news
Sector news : Pharmaceuticals - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09/23 Priority Review Vouchers Revisited
09/23 Bubble Stocks Top The Takeover Premium Charts
09/22 Biotech ETF IBB Could Get A Boost From A Potential Gilead Merger Or Acquisiti..
09/22 Biontech Deal Sees Roche Bet On mRNA
09/21 Roche Holding (RHHBY) Presents at Bank of America Merrill Lynch 2016 Global H..
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 297  CHF
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Daniel O'Day COO-Roche Pharmaceuticals Division
Roland Diggelmann COO-Roche Diagnostics Division
Alan Hippe Chief Financial & Information Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-11.32%218 395
JOHNSON & JOHNSON15.66%325 050
NOVARTIS AG-8.70%214 744
PFIZER INC.6.13%207 809
MERCK & CO., INC.19.20%174 098
GLAXOSMITHKLINE PLC20.39%104 476
More Results